DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anna Nowak, MD
Faculty of Health and Medical Sciences University of Western Australia
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
57 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Canberra Hospital
Garran, Australian Capital Territory, Australia
- Blacktown Hospital
Blacktown, New South Wales, Australia
- Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
- Coffs Harbour Health Campus
Coffs Harbour, New South Wales, Australia
- Gosford Hospital
Gosford, New South Wales, Australia
- Wyong Hospital
Hamlyn Terrace, New South Wales, Australia
- Nepean Hospital
Kingswood, New South Wales, Australia
- Liverpool Hospital
Liverpool, New South Wales, Australia
- Orange Health Service
Orange, New South Wales, Australia
- Northern Cancer Institute (genesiscare)
Saint Leonards, New South Wales, Australia
- Calvary Mater Newcastle
Waratah, New South Wales, Australia
- Westmead Hospital
Westmead, New South Wales, Australia
- Icon Cancer Care Wesley
Auchenflower, Queensland, Australia
- Sunshine Coast University Hospital
Birtinya, Queensland, Australia
- Icon Cancer Care Chermside
Chermside, Queensland, Australia
- the Prince Charles Hospital
Chermside, Queensland, Australia
- Townsville University Hospital
Douglas, Queensland, Australia
- Icon Cancer Care South Brisbane
South Brisbane, Queensland, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Flinders Medical Centre
Bedford Park, South Australia, Australia
- the Queen Elizabeth Hospital
Woodville South, South Australia, Australia
- Royal Hobart Hospital
Hobart, Tasmania, Australia
- Launceston General Hospital
Launceston, Tasmania, Australia
- Monash Health
Clayton, Victoria, Australia
- Peninsula & South Eastern Haematology and Oncology Group
Frankston, Victoria, Australia
- Austin Hospital
Heidelberg, Victoria, Australia
- Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
- Epworth Healthcare - Richmond
Richmond, Victoria, Australia
- Sunshine Hospital (western Health)
Saint Albans, Victoria, Australia
- Goulburn Valley Health
Shepparton, Victoria, Australia
- Sir Charles Gairdner Hospital (scgh)
Nedlands, Western Australia, Australia
- Auckland City Hospital
Grafton, Auckland, New Zealand
- University of California San Diego
La Jolla, California, United States
- University of Miami
Miami, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Emory University
Atlanta, Georgia, United States
- University of Chicago
Chicago, Illinois, United States
- Northshore University Health System/kellogg Cancer Center
Evanston, Illinois, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Feb 2021
- Primary completion
- 20 Jun 2025
- Completion
- 30 Jun 2025
- Last update posted
- 22 Jan 2026
- Registered enrollment
- 214
- Registry id
- NCT04334759
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.